z-logo
open-access-imgOpen Access
Rethinking the Accelerated Approval Pathway at the FDA
Author(s) -
Peggy Eastman
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000725536.79564.52
Subject(s) - food and drug administration , medicine , approved drug , drug development , clinical trial , drug approval , white paper , expanded access , clinical research , covid-19 , flexibility (engineering) , pandemic , cancer drugs , drug , pharmacology , oncology , political science , management , law , disease , infectious disease (medical specialty) , economics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom